Zhenzhen Li, Chaoliang Xiong, Jin Wei, Ping Chen, Yanping Zhang, Huange Zhu, Yuqi Zhao, Wei Lu, Qian He, Yan Geng, Jianhong Zhu. Identification of potential key genes in anaplastic thyroid cancer using bioinformatics analysis[J]. Blood&Genomics, 2022, 6(1): 53-61. DOI: 10.46701/BG.2022012022004
Citation: Zhenzhen Li, Chaoliang Xiong, Jin Wei, Ping Chen, Yanping Zhang, Huange Zhu, Yuqi Zhao, Wei Lu, Qian He, Yan Geng, Jianhong Zhu. Identification of potential key genes in anaplastic thyroid cancer using bioinformatics analysis[J]. Blood&Genomics, 2022, 6(1): 53-61. DOI: 10.46701/BG.2022012022004

Identification of potential key genes in anaplastic thyroid cancer using bioinformatics analysis

  • Anaplastic thyroid cancer (ATC) has a high degree of malignancy and poor prognosis. The purpose of this study was to determine differentially expressed genes (DEGs) in ATC through biometric analysis technology, clarify potential interactions between them, and screen genes related to the prognosis of ATC. Using obtained DEGs, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Protein-protein interaction (PPI), and survival analysis were performed. After R integration analysis of the four datasets, 764 DEGs were obtained, i.e., 314 upregulated genes and 450 downregulated genes. Among the hub DEGs obtained from the PPI network, the expression levels of TYMS, FN1, CHRDL1, SDC2, ITGA2, COL1A1, COL9A3, and COL23A1 were associated with ATC prognosis. These results showed that the recurrence-free survival (RFS) of ATC was associated with TYMS, FN1, ITGA2, COL23A1, SDC2, and CHRDL1 statistically significantly in the KM plotter (P<0.05). Thus, the study suggests that TYMS, FN1, ITGA2, COL23A1, SDC2, and CHRDL1 may be used as potential biomarkers of ATC. These findings provide new insights for the detection of novel diagnostic and therapeutic biomarkers for ATC.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return